GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 833 filers reported holding GLAXOSMITHKLINE PLC in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $208,000 | +0.5% | 4,769 | +0.5% | 0.01% | 0.0% |
| Q1 2022 | $207,000 | -6.3% | 4,743 | -5.5% | 0.01% | 0.0% |
| Q4 2021 | $221,000 | +30.0% | 5,020 | +5.1% | 0.01% | +8.3% |
| Q1 2021 | $170,000 | +132.9% | 4,775 | +147.7% | 0.01% | +9.1% |
| Q1 2020 | $73,000 | -64.7% | 1,928 | -56.3% | 0.01% | -57.7% |
| Q4 2019 | $207,000 | +18.3% | 4,416 | +7.7% | 0.03% | +4.0% |
| Q3 2019 | $175,000 | -3.8% | 4,099 | -9.6% | 0.02% | -13.8% |
| Q2 2019 | $182,000 | +9.6% | 4,536 | +14.1% | 0.03% | +3.6% |
| Q1 2019 | $166,000 | +7.8% | 3,976 | -1.1% | 0.03% | -6.7% |
| Q4 2018 | $154,000 | +2.0% | 4,020 | +6.6% | 0.03% | +7.1% |
| Q3 2018 | $151,000 | -5.6% | 3,771 | -5.3% | 0.03% | -9.7% |
| Q2 2018 | $160,000 | +15.1% | 3,981 | +11.5% | 0.03% | 0.0% |
| Q1 2018 | $139,000 | +98.6% | 3,570 | +80.8% | 0.03% | +72.2% |
| Q4 2017 | $70,000 | -51.0% | 1,975 | -43.9% | 0.02% | -57.1% |
| Q3 2017 | $143,000 | +1942.9% | 3,520 | +1982.8% | 0.04% | +1300.0% |
| Q2 2017 | $7,000 | – | 169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |